SCHEMBL9103407

SCHEMBL9103407

Cc1ccc2c(c1)Oc1ncc(N)cc1C(=O)N2C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.38
PIK3C2G O75747 3/20 0.38
PIK3CG P48736 3/20 0.38
AURKA O14965 2/20 0.38
AURKB Q96GD4 2/20 0.38
NR1H2 P55055 2/20 0.38
NR1H3 Q13133 2/20 0.38
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NUAK1 O60285 2/20 0.33
APP P05067 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
RAB9A P51151 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9100124 0.85 NR1H2 (0.40) PIK3CDPIK3C2GPIK3CGAURKAAURKB
SCHEMBL9101244 0.81 CASP1 (0.45) PIK3CDPIK3C2GPIK3CGAURKAAURKB
SCHEMBL9100099 0.80 RAF1 (0.32) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL9101978 0.80 MAPT (0.53) MAPTLMNASMN1; SMN2POLBMEN1
SCHEMBL9004267 0.79 NR1H2 (0.47) PIK3CDPIK3C2GPIK3CGAURKAAURKB
SCHEMBL9101169 0.72 NR1H2 (0.38) PIK3CDPIK3C2GPIK3CGAURKAAURKB
SCHEMBL9097611 0.71 MAPT (0.36) MAPTLMNASMN1; SMN2POLB
SCHEMBL9101666 0.71 MAPT (0.34) MAPTLMNASMN1; SMN2POLB
SCHEMBL17975298 0.69 NR1H2 (0.45) PIK3CDPIK3C2GPIK3CGAURKAAURKB
SCHEMBL9927344 0.67 NISCH (0.36) NR1H2NR1H3MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5550122-A INHIBIT REVERSE TRANSCRIPTASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US claimed
EP-0415303-B1 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1995-12-13 EP claimed
EP-0415303-A2 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-03-06 EP claimed
JP-4178390-A None JP disclosed
US-5550122-A INHIBIT REVERSE TRANSCRIPTASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US disclosed
EP-0415303-B1 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1995-12-13 EP disclosed
JP-H04178390-A PYRIDO(2,3-B)(1,5)BENZOXAZEPIN (AND THIAZEPIN)-5(6H)-ONES AND THIONES AND PHARMACEUTICAL FORMULATOR CONTAING THEM FOR PROPHYLANIS AND TREATMENT OF HIV INFECTIOUS DISEASE BOEHRINGER INGELHEIM PHARMACEUT INC 1992-06-25 JP disclosed
EP-0415303-A2 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-03-06 EP disclosed